o-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis

Carcinogenesis

Volumn 25, Issue 4, 2004, Pages 605-612

  Sills, R C ^a   Hong, H L ^a   Flake, G ^a   Moomaw, C ^a   Clayton, N ^a   Boorman, G A ^a   Dunnick, J ^a   Devereux, T R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 NITROTOLUENE; APC PROTEIN; BETA CATENIN; CYCLIN D1; CYTOKERATIN 20; CYTOKERATIN 7; GLYCINE; K RAS PROTEIN; PROTEIN P53; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BIOASSAY; CECUM CARCINOMA; CELL CYCLE G1 PHASE; CODON; COLON CANCER; COLON CARCINOGENESIS; COLUMNAR EPITHELIUM; CONTROLLED STUDY; EXON; EXPOSURE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; IMMUNOHISTOCHEMISTRY; LARGE INTESTINE TUMOR; MALE; MORPHOLOGY; MOUSE; MOUSE STRAIN; MUTATIONAL ANALYSIS; NONHUMAN; ONCOGENE; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAINING; TUMOR SUPPRESSOR GENE;

ANIMALS; BASE SEQUENCE; BETA CATENIN; CARCINOGENS; CECAL NEOPLASMS; CODON; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; HUMANS; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED STRAINS; TOLUENE; TRANS-ACTIVATORS;

EID: 16544375688     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh044     Document Type: Article

References (51)

1. Fearon,E.R. and Vogelstein,B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
2. Kinzler,K.W. and Vogelstein,B. (1996) Lessons from heriditary colorectal cancer. Cell, 87, 159-170.
3. Lynch,H.T. and de la Chapelle,A. (2003) Hereditary colorectal cancer. N. Engl. J. Med., 348, 919-932.
4. Iwao,K., Nakamori,S., Kameyama,M., Imaoka,S., Kinoshita,M., Fukui,T., Ishiguro,S., Nakamura,Y. and Miyoshi,Y. (1998) Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinoma without adenomatous polyposis coli mutations. Cancer Res., 58, 1021-1026.
5. Wagenaar,R.A., Crawford,H.C. and Matrisian,L.M. (2001) Stabilized beta-catenin immortalizes colonic epethelial cells. Cancer Res., 61, 2097-2104.
6. Peifer,M. (1997) β-catenin as oncogene: the smoking gun. Science, 275, 1752-1753.
7. Bienz,M. and Clevers,H. (2000) Linking colorectal cancer to Wnt signaling. Cell, 103, 311-320.
8. Bos,J.L., Fearon,E.R., Hamilton,S.R., Vries,M.V., van Boom,J.H., van der Eb,A.J. and Vogelstein,B. (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature, 327, 293-297.
9. Johnstone,C.N., Chang,L.M. and Ernst,M. (2002) AACR special meeting in cancer research: colon cancer - genetics to prevention. Cancer Res., 62, 6779-6783.
10. Willett,W. (1989) The search for the causes of breast and colon cancer. Nature, 338, 389-394.
11. Huff,J., Cirvello,J., Haseman,J. and Bucher,J. (1991) Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ. Health Perspect., 93, 247-270.
12. Dunnick,J.K., Burka,L.T., Mahler,J. and Sills,R. (2003) Carcinogenic potential of o-nitrotoluene and p-nitrotoluene. Toxicology, 183, 221-234.
13. Devereux,T.R., Foley,J.F., Maronpot,R.R., Kari,F. and Anderson,M.W. (1993) Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride. Carcinogenesis, 14, 795-801.
14. Devereux,T.R., Belinsky,S.A., Maronpot,R.R., White,C., Hegi,M., Patel,A.C., Foley,J.F., Greenwell,A. and Anderson,M.W. (1993) Comparison of pulmonary O6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains. Mol. Carcinogen., 8, 177-185.
15. Sills,R.C., Hong,H.L., Melnick,R.L., Boorman,G.A. and Devereux,T.R. (1999) High frequency of codon 61 K-ras A to T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2-years and comparisons with the structurally related chemicals isoprene and 1,3-butadiene. Carcinogenesis, 20, 657-662.
16. Trukhanova,L.S., Hong,H.L., Sills,R.C., Bowser,A.D., Gaul,B., Boorman,G.A., Turusov,V.S., Devereux,T.R. and Dixon,D. (1998) Predominant p53 G to A transition mutation and enhanced cell proliferation in uterine sarcomas of CBA mice treated with 1,2-dimethylhydrazine. Toxicol. Pathol., 26, 367-374.
17. Hong,H.L., Devereux,T.R., Melnick,R.L., Moomaw,C.R., Boorman,G.A. and Sills,R.C. (2000) Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years. Toxicol. Pathol., 28, 529-534.
18. Devereux,T.R., Anna,C.H., Foley,J.F., White,C.M., Sills,R.C. and Barrrett,J.C. (1999) Mutation of β-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene, 18, 4726-4733.
19. Anna,C.H., Sills,R.C., Foley,J.F., Stockton,P.S., Ton,T. and Devereux,T.R. (2000) β-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam. Cancer Res., 60, 2864-2868.
20. Morin,P.J., Sparks,A.B., Korinek,V., Barker,N., Clevers,H., Vogelstein,B. and Kinzler,K.W. (1997) Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science, 275, 1787-1790.
21. Goldstein,N.S., Long,A., Kuan,S. and Hart,J. (2000) Colon signet ring cell adenocarcinoma: Immunohistochemical characterization and comparison with gastric and typical colon adenocarcinomas. Appl. Immunohistochem. Mol. Morphol., 8, 183-188.
22. Iwamoto,M., Ahnen,D.J., Franklin,W.A. and Maltzman,T.H. (2000) Expression of β-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis, 21, 1935-1940.
23. Hegi,M.E., Soderkvist,P., Foley,J.F., Schoonhoven,R., Swenberg,J.A., Kari,F., Maronpot,R., Anderson,M.W. and Wiseman,R.W. (1993) Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Carcinogenesis, 14, 803-810.
24. Anna,C.H., Iida,M., Sills,R.C. and Devereux,T.R. (2003) Expression of potential β-catenin targets, cyclin D1, c-jun, c-myc, e-cadherin and egfr in chemically induced hepatocellular neoplasms from B6C3F1 mice. Toxicol. Appl. Pharmacol., 190, 135-145.
25. Sills,R.C., Hong,H.L., Greenwell,A., Herbert,R.A., Boorman,G.A. and Devereux,T.R. (1995) Increased frequency of K-ras mutations in lung neoplasms from female B6C3F1 mice exposed to ozone for 24 or 30 months. Carcinogenesis, 16, 1623-1628.
26. Devereux,T.R., Anderson,M.W. and Belinsky,S.A. (1991) Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse. Carcinogenesis, 12, 299-303.
27. Devereux,T.R., Holliday,W., Anna,C., Ress,N., Roycroft,J. and Sills,R.C. (2002) Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years. Carcinogenesis, 23, 1737-1743.
28. Rosai,J. (ed.) (2002) Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, DC.
29. Yamada,Y., Oyama,T.,Hirose,Y.,Hara,A.,Sugie,S., Yoshida,K., Yoshimi,N. and Mori,H. (2003) β-Catenin mutation is selected during malignant transformation in colon carcinogenesis. Carcinogenesis, 24, 91-97.
30. Mirabelli-Primdahl,L., Gryfe,R., Kim,H., Millar,A., Luceri,C., Dale,D., Holowaty,E., Bapat,B., Gallinger,S. and Redston,M. (1999) β-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res., 59, 3346-3351.
31. Fodde,R., Smits,R. and Clevers,H. (2001) APC, signal transduction and genetic instability in colorectal cancer. Nature Rev. Cancer, 1, 55-67.
32. Murata,M., Iwao,K., Miyoshi,Y. et al. (2000) Activation of the β-catenin gene by interstitial deletions involving exon 3 as an early event in colorectal tumorigenesis. Cancer Lett., 159, 73-78.
33. Tetsu,O. and McCormick,F. (1999) β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 389, 422-426.
34. Devereux,T.R., Stern,M.C., Flake,G.P., Yu,M.C., Zhang,Z., London,S.J. and Taylor,J.A. (2001) CTNNB1 mutations and β-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1. Mol. Carcinogen., 31, 68-73.
35. Koch,A., Denkhaus,D., Albrecht,S., Leuschner,I., von Schweinitz,D. and Pietsch,T. (1999) Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene. Cancer Res., 59, 269-273.
36. Shtutman,M., Zhurinsky,J., Simcha,I., Albanese,C., D'Amico,M., Pestell,R. and Ben-Ze'ev,A. (1999) The cyclin D1 gene is a target of the β-catenin/ LEF-1 pathway. Proc. Natl Acad. Sci. USA, 96, 5522-5527.
37. Marques,M.M., Mourato,L.L.G., Amorim,M.T., Santos,M.A., Melchior,W.B. and Beland,F.A. (1997) Effect of substitution site upon the oxidation potentials of alkylanilines, the mutagenicities of n-hydroxyalkylanilines and the conformations of alkylaniline-DNA adducts. Chem. Res. Toxicol., 10, 1266-1274.
38. Mass,M.J., Jefferson,A.M., Ross,J.A., Nelson,G., Galati,A.L., Stoner,G.D. and Nesnow,S. (1993) Ki-ras oncogene mutations in tumors and DNA adducts formed by benz[j]aceanthylene and benzo[a]pyrene in the lungs of strain A/J mice. Mol. Carcinogen., 8, 186-192.
39. Jelinsky,S.A., Liu,T., Geacintov,N.E. and Loechler,E.L. (1995) The major, N2-gua adduct of the (+)-anti-benzo[a]pyrene diol epoxide is capable of inducing G to A and G to C, in addition to G to T, mutations. Biochemistry, 34, 13545-13553.
40. Loeb,L.A. (2001) A mutator phenotype in cancer. Cancer Res., 61, 3230-3239.
41. Zhang,Z., Wang,Y., Vikis,H.G. et al. (2001) Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nature Genet., 29, 25-33.
42. Greenblatt,M.S., Bennett,W.P., Hollstein,M. and Harris,C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
43. Harris,C.C. (1996) Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic stratagies. J. Natl Cancer Inst., 88, 1442-1455.
44. Kahlenberg,M.S., Stoler,D.L., Basik,M., Petrelli,N.J., Rodriguez-Bigas,M. and Anderson,G.R. (1996) p53 Tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancers. J. Natl Cancer Institute, 88, 1665-1670.
45. Bardelli,A., Cahill,D.S.,, Lederer,G., Speicher,M.R., Kinzler,K.W., Vogelstein,B. and Lengauer,C. (2001) Carcinogen-specific induction of genetic instability. Proc. Natl Acad. Sci. USA, 98, 5770-5775.
46. Lengauer,C., Kinzler,K.W. and Vogelstein,B. (1997) Genetic instability in colorectal cancer. Nature, 386, 623-627.
47. Wang,T.-L., Rago,C., Silliman,N., Ptak,J., Markowitz,S., Wilson,J.K.V., Parmigiani,G., Kinzler,K.W., Vogelstein,B. and Velculescu,V.E. (2002) Prevalence of somatic alterations in the colorectal cancer cell genome. Proc. Natl Acad. Sci. USA, 99, 3076-3080.
48. Zhang,T., Nanney,L.B., Luongo,C., Lamps,L., Heppner,K.J., DuBois,R.D. and Beauchamp,R.D. (1997) Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (min) mice and human familial adenomatous polyposis patients. Cancer Res., 57, 169-175.
49. Parada,L.F., Land,H., Weinberg,R.A., Wolf,D. and Rotter,V. (1984) Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature, 312, 649-651.
50. Hanahan,D. and Weingurg,R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
51. McCormick,F. (1999) Signalling networks that cause cancer. Trends Cell Biol., Millennium Issue, M53-M56.